The largest database of trusted experimental protocols

Hkca tlrl hkca

Manufactured by InvivoGen
Sourced in United States

HKCA-#tlrl-hkca is a laboratory equipment product. It serves as a core function, but a detailed description cannot be provided while maintaining an unbiased and factual approach.

Automatically generated - may contain errors

2 protocols using hkca tlrl hkca

1

Immunogenicity of HEWL, HKCA, and Quil-A Adjuvant in Dairy Bulls

Check if the same lab product or an alternative is used in the 5 most similar protocols
We randomly selected six healthy dairy bulls aged between 4.9–6.7 years and weighing 1000–1100 kg for this study. The six bulls were Holstein breed with similar genetic merit. They were of various genetic backgrounds, according to the pedigree information. Additionally, principal component analysis (PCA) was carried out to analyze the genetic relationships among these animals based on genotypes, showing no significant clustering according to Supplementary Materials File S1: Figure S1. All experimental animals received no veterinary treatment during the course of the experiment. Immunization protocols were conducted from September 2021 to October 2021, and AMIR indicators were evaluated by modified ELISA based on a previous study [6 (link)]. On d0 and d14, the bulls received an intramuscular injection of 0.5 mg of hen egg white lysozyme (HEWL; Sigma L4919, Shanghai, China), 0.5 mg heat-killed Candida albicans (HKCA-#tlrl-hkca, InvivoGen, San Diego, USA), and 0.5 mg of Quil-A adjuvant (#vacquil, InvivoGen, Toulouse, France) dissolved in 1 mL of phosphate-buffered saline (PBS, pH 7.4). On both sides of the neck, an intramuscular injection of 1 mL was given using a single-use needle. The workflow of this study is summarized in Figure 1.
+ Open protocol
+ Expand
2

Immune Response Modulation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heat-killed C. albicans (HKCA; tlrl-hkca), zymosan (tlrl-zyn) and Trehalose-6,6-dibehenate (TDB; tlrl-tdb) were purchased from Invivogen. Mannan (M3640) were purchased from Sigma-Aldrich. The HDAC11 inhibitors FT895 (HY-112285) and SIS17 (HY-128918), SYK inhibitor R406 (HY-12067), NF-κB inhibitor JSH-23 (HY-13982) and STAT3 inhibitor STAT3-IN-1 (HY-100753) were purchased from MedChemExpress. iNOS inhibitors S-methylisothiourea hemisulfate salt (SMT; S0008) and L-NMMA (S0011) were purchased from Beyotime Biotechnology. The SYK inhibitor R406 (S2194) was purchased from Selleck. The antibodies used in this study shown in Supplementary Table 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!